Tingting
Yang
a,
Lin
Lia
a,
Cai
Heng
b,
Pian
Sha
a,
Yiying
Wang
a,
Jiaming
Shen
a,
Zhenzhou
Jiang
c,
Sitong
Qian
a,
Chujing
Wei
c,
Hao
Yang
e,
Xia
Zhu
a,
Tao
Wang
d,
Mengying
Wu
c,
Jianyun
Wang
a,
Qian
Lu
a and
Xiaoxing
Yin
*a
aJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China
bDepartment of Pharmacy, JingJiang People's Hospital, Jingjiang 214500, China
cNew Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China
dDepartment of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China
eDepartment of Pharmacy, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou 213000, China
First published on 15th February 2024
Removal of Expression of Concern for ‘Sodium butyrate ameliorated diabetic nephropathy-associated tubulointerstitial inflammation by modulating tight junction of renal tubular epithelial cells’ by Tingting Yang et al., Food Funct., 2022, Accepted Manuscript, https://doi.org/10.1039/D2FO00940D.
In order to ensure the reliability of the western blot data in the Accepted Manuscript, the authors were asked to provide higher quality images. They repeated the experiments and new western blot data is provided in this version. The full blots have been assessed by an expert and concluded that the outcomes and conclusions are unchanged.
This notice supersedes the information provided in the Expression of Concern related to this article.
Rebecca Garton
12th February 2024
Executive Editor, Food & Function
This journal is © The Royal Society of Chemistry 2024 |